Curi RMB Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,700
| Closed | -$237K | – | 767 |
|
|
2019
Q2 | $237K | Hold |
2,700
| – | – | 0.01% | 636 |
|
|
2019
Q1 | $244K | Buy |
+2,700
| New | +$244K | 0.01% | 675 |
|
|
2018
Q4 | – | Sell |
-3,557
| Closed | -$341K | – | 961 |
|
|
2018
Q3 | $341K | Buy |
3,557
+697
| +24% | +$66.8K | 0.01% | 675 |
|
|
2018
Q2 | $272K | Sell |
2,860
-13,597
| -83% | -$1.29M | 0.01% | 723 |
|
|
2018
Q1 | $1.44M | Sell |
16,457
-100
| -0.6% | -$8.77K | 0.04% | 413 |
|
|
2017
Q4 | $1.41M | Hold |
16,557
| – | – | 0.04% | 406 |
|
|
2017
Q3 | $1.43M | Hold |
16,557
| – | – | 0.04% | 360 |
|
|
2017
Q2 | $1.28M | Buy |
16,557
+157
| +1% | +$12.1K | 0.04% | 392 |
|
|
2017
Q1 | $1.14M | Buy |
16,400
+3,400
| +26% | +$236K | 0.05% | 260 |
|
|
2016
Q4 | $769K | Buy |
+13,000
| New | +$769K | 0.04% | 248 |
|